Vanda Pharmaceuticals (VNDA) Work In Process (2014 - 2017)

Vanda Pharmaceuticals has reported Work In Process for 4 years, with the latest figure at $80000.0 in Q4 2017.

• Quarterly Work In Process rose 370.59% year-over-year to $80000.0 in Q4 2017, while the trailing twelve-month figure through Dec 2017 was $80000.0 (up 370.59% YoY) and the FY2017 annual result came in at $80000.0, up 370.59% from the prior year.
• Work In Process rose to $80000.0 in Q4 2017 per VNDA's latest filing, from $63000.0 in the prior quarter.
• Over five years, Work In Process peaked at $1.8 million in Q2 2015 and troughed at $7000.0 in Q2 2014.
• A 4-year average of $564833.3 and a median of $71500.0 in 2017 frame the typical range for Work In Process.
• The sharpest annual moves came in 2015 and 2017: Work In Process surged 25300.0% in 2015, then soared 370.59% in 2017.
• Over 4 years, Work In Process stood at $1.3 million in 2014, then climbed by 19.0% to $1.6 million in 2015, then slumped by 98.92% to $17000.0 in 2016, then jumped by 370.59% to $80000.0 in 2017.
• According to Business Quant data, Work In Process over the past three periods registered $80000.0, $63000.0, and $131000.0 for Q4 2017, Q3 2017, and Q2 2017 respectively.